No Data
No Data
We Think Sichuan Biokin PharmaceuticalLtd's (SHSE:688506) Profit Is Only A Baseline For What They Can Achieve
Subdued Growth No Barrier To Sichuan Biokin Pharmaceutical Co.,Ltd.'s (SHSE:688506) Price
Baili Tianheng: Sichuan Baili Tianheng Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024
Sichuan Baili Tianheng Pharmaceutical Co., Ltd. Report for the third quarter of 2024
Baoli Tianheng (688506.SH) released its performance for the first three quarters, with a net income of 4.065 billion yuan.
Baolitinheng (688506.SH) released the third quarter report of 2024, with revenue of 56...
Bailitianheng (688506.SH): The net income for the first three quarters was 4.065 billion yuan.
GeLongHui reported its third quarter results on October 28. The revenue for the first three quarters was 5.66 billion yuan, a year-on-year increase of 1399.22%. The net income was 4.065 billion yuan, with a non-net profit of 4.04 billion yuan, and basic earnings per share of 10.14 yuan.
No Data
No Data